- Imatinib in the first-line treatment of chronic myelogenous leukemia in chronic phase2008 | First Faculty of Medicine
- Imatinib in the first-line treatment of chronic myelogenous leukemia in chronic phase2008 | Publication without faculty affiliation
- Persistent splenomegaly during imatinib therapy and the definition of complete hematological response in chronic myelogenous leukemia2010 | Faculty of Medicine in Hradec Králové
- Imatinib mesylate is effective in children with chronic myelogenous leukemia in late chronic and advanced phase and in relapse after stem cell transplantation2006 | Second Faculty of Medicine
- Mechanism of impaired glucose metabolism during nilotinib therapy in patients with chronic myelogenous leukemia2013 | First Faculty of Medicine
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. AV001Publication without faculty affiliation
- Real-Time Analysis of Imatinib- and Dasatinib-Induced Effects on Chronic Myelogenous Leukemia Cell Interaction with Fibronectin2014 | Faculty of Science
- Inhibition of casein kinase 2 induces cell death in tyrosine kinase inhibitor resistant chronic myelogenous leukemia cells2023 | Faculty of Science, Central Library of Charles University
- Prevention of product carryover by single tube two-round PCR: Aplication to BCR/ABL analysis in chronic myelogenous leukemia1995 | Second Faculty of Medicine
- Differentiating juvenile myelomonocytic leukemia from infectious disease - Response1998 | Second Faculty of Medicine
- Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party2016 | Publication without faculty affiliation
- Sequential cytogenetic study of patients after bone marrow transplantation1994 | Second Faculty of Medicine
- BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia.2018 | First Faculty of Medicine, Central Library of Charles University
- LIN28B overexpression defines a novel fetal-like subgroup of juvenile myelomonocytic leukemia2016 | Second Faculty of Medicine
- Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib2017 | Publication without faculty affiliation
- Allogenic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: A report from the European Working Group on Myelodysplastic Syndrome in Childhood1997 | Second Faculty of Medicine
- Somatic Mutations in Oncogenes Are in Chronic Myeloid Leukemia Acquired De Novo via Deregulated Base-Excision Repair and Alternative Non-Homologous End Joining2021 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcome2011 | Second Faculty of Medicine
- Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia2015 | Second Faculty of Medicine
- Interferon-alpha Revisited: Individualized Treatment Management Eased the Selective Pressure of Tyrosine Kinase Inhibitors on BCR-ABL1 Mutations Resulting in a Molecular Response in High-Risk CML Patients2016 | First Faculty of Medicine, Faculty of Science, Third Faculty of Medicine
- Changes of Immunological Profiles in Patients with Chronic Myeloid Leukemia in the Course of Treatment2010 | Second Faculty of Medicine
- Prognostic discrimination based on the EUTOS long-term survival score within the International Registry for Chronic Myeloid Leukemia in children and adolescents2017 | Second Faculty of Medicine
- European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms2019 | First Faculty of Medicine
- Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial2018 | Second Faculty of Medicine
- Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial2005 | Second Faculty of Medicine
- Chronic myeloid leukemia. Recommendations for diagnosis, monitoring and treatment of CML in adults, updated version 20112011 | Faculty of Medicine in Hradec Králové
- Where does treatment of chronic myeloid leukemia target tyrosine kinase inhibitors?2018 | First Faculty of Medicine
- Long-term follow-up of chimerical state of the patients transplanted for different haematologic diseases2003 | Second Faculty of Medicine
- Hematopoietic stem cell transplantation in children with hematological malignancies across HLA barriers - reasonable alternative?2001 | Second Faculty of Medicine
- Program of Hematopoietic Stem Cell Transplantation in Children at Department of Pediatric Hematology and Oncology, University Hospital Motol - from Fetal Liver to Cord Blood2007 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
